Time Course Change in Skeletal Muscle and Blood Phospholipid Composition With Omega-3 Fatty Acid Supplementation
1 other identifier
interventional
29
1 country
1
Brief Summary
Increased omega-3 fatty acid composition of human skeletal muscle phospholipids is linked to improved skeletal muscle strength and growth in women and men. However, what is unknown is if biological sex influences skeletal muscle phospholipid composition in response to omega-3 fatty acid supplementation. Moreover, whilst time course changes in skeletal muscle phospholipid composition with omega-3 fatty acid intake have been established, no study has characterized a washout of omega-3 fatty acids from skeletal muscle phospholipids following cessation of omega-3 fatty acid intake. Thus, the aim of the present investigation is to establish a time course change and washout of omega-3 fatty acids from skeletal muscle phospholipids in response to omega-3 fatty acid intake. The investigators also aim to establish if this washout is impacted by biological sex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2025
CompletedJanuary 29, 2025
January 1, 2024
1.4 years
July 18, 2023
January 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in skeletal muscle EPA and DHA content
Skeletal muscle phospholipid composition will be assessed at all time points by means of gas chromatography
At 0, 6, 8, 16, 20, and 22 weeks.
Secondary Outcomes (7)
Changes in the expression of mitochondrial related proteins
0, 6, 8, 16, 20, and 22 weeks.
Changes in erythrocyte EPA and DHA content
0, 6, 8, 16, 20, and 22 weeks.
Changes in the expression of translational factors related to skeletal muscle protein synthesis
0, 6, 8, 16, 20, and 22 weeks.
Changes in circulating glucose concentrations
0, 6, 8, 16, 20, and 22 weeks.
Changes in circulating insulin concentrations
0, 6, 8, 16, 20, and 22 weeks.
- +2 more secondary outcomes
Study Arms (1)
Fish Oil Group
EXPERIMENTALAll participants will be placed in this group
Interventions
Participants in this group will receive 5g fish oil with high EPA and DHA content per day
Eligibility Criteria
You may qualify if:
- Males and females 19-30 years
- BMI between 18-29 kg/m2
- Free of musculoskeletal injuries
- Participants not currently pregnant
- Participants willing to maintain current use of contraceptives or post-menopausal supplementation if any for the duration of the study.
- Not allergic to fish
- COVID-19 vaccinated to comply with Queen's University's return to campus guidelines, unless exempt by reasons from the Ontario Human Rights Code
- Recreationally active
You may not qualify if:
- Any muscular, neurological, respiratory or metabolic disease including diabetes
- Any form of cancer currently or in the last 5 years
- Currently taking fish oil supplements
- Currently taking any form of steroid
- Consuming \>2 oily fish meals per week
- Pregnant
- Any current illness
- Any current/past lower limb injury/surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Kinesiology and Health Studies
Kingston, Ontario, K7L 3N6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris McGlory, PhD
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- All participants will take part in the same intervention, which will be fully disclosed to each participant.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 18, 2023
First Posted
August 2, 2023
Study Start
August 1, 2023
Primary Completion
December 31, 2024
Study Completion
January 13, 2025
Last Updated
January 29, 2025
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
Data will be retained by the investigators, and shared under reasonable request.